Table 4 Results of the two diagnostic pathways including costs* and cost-effectiveness in US$. (N = 998)
ZN followed by CXR (n = 998). | CXR followed by ZN (n = 998) | |
|---|---|---|
Number of culture positive suspects | 559 | 559 |
Number of patient put on treatment | 666 | 551 |
Number Culture pos. patient put on treatment | 514 | 496 |
C+/ZN+ patients put on treatment | 335 | 308 |
C+/ZN- patient put on treatment | 179 | 188 |
Number Culture neg. patients put on treatment (Over diagnosis) | 152 | 56 |
Number Culture pos. patients not put on treatment (Under diagnosis) | 45 | 63 |
Laboratory service | ||
Labour costs | $973 | $973 |
Investment costs | $135 | $135 |
Running costs | $1,706 | $1,151 |
Total laboratory costs | $2,814 | $2,259 |
X-ray service | ||
Labour costs | 154 | $154 |
Investment costs | 237 | $237 |
Running costs | 1,278 | $1,946 |
Total CXR service costs | 1,669 | $2,337 |
Total diagnostic costs | $4,483 | $4,596 |
Cost per correctly diagnosed patient | $8.72 | $9.27 |
Total treatment costs ** | $76,565 | $63,422 |
Diagnostic costs + treatment costs | $81,048 | $68,018 |
Cost per correct diagnosed patient including costs of treatment. | $158 | $137 |